REGISTERED NUMBER: 14109883 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 May 2025

for

ANJALINAS HEALTH LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Dr P Orakkan

Dr S Pradeep

REGISTERED OFFICE:

Kensington House

3 Kensington

Bishop Auckland

Co. Durham

DL14 6HX

REGISTERED NUMBER:

14109883 (England and Wales)

ACCOUNTANTS:

Mitchells Grievson

Chartered Accountants

Kensington House

3 Kensington

Bishop Auckland

Co. Durham

DL14 6HX

FIXED ASSETS

Tangible assets

4

119,861

158,572

Investments

5

109,389

89,433

229,250

248,005

CURRENT ASSETS

Debtors

6

256,065

116,520

Cash at bank

448,454

293,010

704,519

409,530

CREDITORS

Amounts falling due within one year

7

94,217

55,251

NET CURRENT ASSETS

610,302

354,279

TOTAL ASSETS LESS CURRENT LIABILITIES

839,552

602,284

PROVISIONS FOR LIABILITIES

29,965

39,643

NET ASSETS

809,587

562,641

CAPITAL AND RESERVES

Called up share capital

200

200

Retained earnings

809,387

562,441

809,587

562,641

The Company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2025.

The members have not required the Company to obtain an audit of its financial statements for the year ended 31 May 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 January 2026 and were signed on its behalf by:

Dr P Orakkan - Director

1.	STATUTORY INFORMATION

Anjalinas Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Motor vehicles

-

25% on reducing balance

Computer equipment

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Motor

Computer

vehicles

equipment

Totals

£

£

£

COST

At 1 June 2024

181,836

499

182,335

Additions

-

1,118

1,118

At 31 May 2025

181,836

1,617

183,453

DEPRECIATION

At 1 June 2024

23,650

113

23,763

Charge for year

39,546

283

39,829

At 31 May 2025

63,196

396

63,592

NET BOOK VALUE

At 31 May 2025

118,640

1,221

119,861

At 31 May 2024

158,186

386

158,572

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST

At 1 June 2024

89,433

Additions

19,956

At 31 May 2025

109,389

NET BOOK VALUE

At 31 May 2025

109,389

At 31 May 2024

89,433

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

256,065

116,520

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

92,326

53,360

Other creditors

1,891

1,891

94,217

55,251

8.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 May 2025 and 31 May 2024:

2025

2024

£

£

Dr P Orakkan

Balance outstanding at start of year

111,790

326,946

Amounts advanced

275,898

173,876

Amounts repaid

(134,442

)

(389,032

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

253,246

111,790

The director's loan account is repayable upon demand and interest has been charged at the relevant rate during the year.